Sulphapyridine--a new agent for the treatment of ocular cicatricial pemphigoid.
AIMS--Ocular cicatricial pemphigoid (OCP) is a severe, potentially sight threatening systemic disease that sometimes requires systemic immunosuppression. This study assessed the clinical outcome of patients with OCP treated with sulphapyridine, a sulphonamide with an anti-inflammatory and immunosupp...
Gespeichert in:
| Veröffentlicht in: | Br J Ophthalmol |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMJ Publishing Group
1996
|
| Schlagworte: | |
| Online-Zugang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC505530/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8759268/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/bjo.80.6.549 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
